IDO2 and cancer: It has recently been documented that Bin1 loss can promote immune escape in cancer by deregulating the immunomodulatory enzyme indoleamine 2, 3-dioxygenase (IDO); IDO inhibitors have also been found to potentiate cancer chemotherapy [87].